Talking Medicines
Talking Medicines provides Pharma and Med Comms agencies with AI-powered intelligence to measure, predict, and prove the impact of scientific messaging on HCPs. Using proprietary platforms, DrugVoice and the Message Resonance Score™, the company addresses a $23Bn marketing blind spot, connecting messaging to real-world prescribing behaviour. Its domain-specific data science enables clients to optimise campaigns, de-risk marketing investment, and demonstrate measurable ROI, positioning Talking Medicines as a strategic, high-value solution in the life sciences marketing ecosystem.
Domain
talkingmedicines.com
Country
United KingdomIndustry
Artificial Intelligence (AI)Employees
11-50
Last Funding
$2.0M
Founded
2013
Tech Stack (28 technologies)
Frequently Asked Questions
What technologies does Talking Medicines use?+
Talking Medicines uses 28 technologies including Google Analytics, Google Tag Manager, jsDelivr.
What industry is Talking Medicines in?+
Talking Medicines operates in the Artificial Intelligence (AI) industry.
Where is Talking Medicines based?+
Talking Medicines is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026